#Global Stem Cell Banking Market Segmentation

[marketanalysisdata]

Biopreservation Market Revenue, Share and Growth Rate to 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Biopreservation Market Competitive Landscape and Industry Analysis 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[latestmarketresearchnews]

Biopreservation Market Growth Drivers With Outlook And Opportunity Forecast To 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.

Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.

Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.

Product Segmentation Insights:

The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.

The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Biopreservation Industry Analysis, Opportunities And Forecast Report, 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.

Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.

Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.

Product Segmentation Insights:

The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.

The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[harshnews]

Thawing Equipment Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Thawing Equipment Market – Industry Trends and Forecast to 2029

Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.

Access Full 350 Pages PDF Report @

**Segments**

- **Material Type:** - Based on material type, the wicketed bags market can be segmented into polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), biodegradable materials, and others. Among these, polyethylene bags are expected to dominate the market due to their cost-effectiveness and versatility in various applications.

- **Closure Type:** - The closure type segment includes options such as resealable zipper closures, heat seal closures, adhesive closures, and others. Resealable zipper closures are gaining popularity due to their convenience and ability to keep the contents fresh for longer durations.

- **End-Use Industry:** - This segment categorizes the wicketed bags market based on end-use industries like food packaging, pharmaceuticals, personal care and cosmetics, industrial, retail, and others. The food packaging industry is anticipated to hold a significant share owing to the increasing demand for convenient and sustainable packaging solutions.

**Market Players**

- **Amcor plc:** - Amcor is a key player in the wicketed bags market, offering a wide range of packaging solutions that cater to various industries. The company focuses on innovation and sustainability to meet the evolving needs of customers.

- **Bemis Company, Inc.:** - Bemis Company is another prominent player known for its advanced packaging technologies, including wicketed bags. The company's strong market presence and focus on product quality have solidified its position in the industry.

- **Berry Global, Inc.:** - Berry Global is a leading manufacturer of wicketed bags, providing customizable packaging solutions to meet specific requirements. The company's robust supply chain and global reach make it a reliable partner for customers worldwide.

- **Mondi plc:** - Mondi is a well-known name in the packaging industry, offering innovative wicketed bag solutions that prioritize sustainability and efficiency. With a strongThe wicketed bags market is witnessing significant growth and evolution driven by various segmentation factors. Material type segmentation plays a crucial role in determining the market landscape. The dominance of polyethylene (PE) bags is primarily attributed to their cost-effectiveness and versatility across different applications. Polypropylene (PP) and polyethylene terephthalate (PET) bags also offer unique advantages, but the eco-friendly trend is fueling the demand for biodegradable materials in wicketed bags. As sustainability becomes a key focus for many industries, the market is likely to witness a shift towards biodegradable options in the coming years.

Closure type segmentation further enhances the customization and functionality of wicketed bags. Resealable zipper closures have gained popularity due to their convenience and ability to maintain product freshness over extended periods. Heat seal closures and adhesive closures also play significant roles in meeting specific requirements of different industries. The choice of closure type can impact consumer convenience, product protection, and overall user experience, making it a crucial element in the wicketed bags market segmentation.

The end-use industry segment categorizes the wicketed bags market based on the applications across various sectors. The food packaging industry is poised to be a key driver of the market growth due to the rising demand for convenient and sustainable packaging solutions. With consumers placing increasing emphasis on convenience and eco-friendliness, wicketed bags offer a practical solution for food packaging companies looking to align with these preferences. Additionally, the pharmaceutical, personal care and cosmetics, industrial, retail, and other industries also contribute to the diverse applications of wicketed bags, showcasing the market's versatility and adaptability to different market demands.

Market players such as Amcor plc, Bemis Company, Inc., Berry Global, Inc., and Mondi plc are key contributors to the growth and innovation in the wicketed bags market. These companies bring a wealth of experience, technological expertise, and a strong focus on sustainability to the table, catering to the**Global Thawing Equipment Market**

- **Product:** - The thawing equipment market is segmented based on product types into manual and automatic thawing equipment. Both manual and automatic thawing equipment play a crucial role in various industries such as blood banks, hospitals, research laboratories, and the pharmaceutical industry, catering to different needs and requirements.

- **Sample:** - The sample segment categorizes the thawing equipment market based on the types of samples being thawed. This includes blood products, ovum/embryo, semen, human tissue samples, organs, stem cells, and other sample types. Each sample category requires specific thawing conditions and protocols, driving the demand for specialized thawing equipment in the market.

- **End User:** - The end-user segment of the thawing equipment market entails blood banks and transfusion centers, hospitals, research laboratories, the pharmaceutical industry, biobanks, and gene banks. Each end user has unique thawing needs based on the samples being handled, highlighting the importance of tailor-made thawing equipment solutions for different applications.

- **Application:** - The application segment further refines the market by categorizing the use of thawing equipment into therapeutic applications, research applications, clinical trials, and other applications. Thawing equipment plays a critical role in ensuring the integrity and viability of samples for various applications, making it a key component in the healthcare and research sectors.

The global thawing equipment market is witnessing significant growth and

Countries Studied:

North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

 Objectives of the Report

To carefully analyze and forecast the size of the Thawing Equipment market by value and volume.

To estimate the market shares of major segments of the Thawing Equipment

To showcase the development of the Thawing Equipment market in different parts of the world.

To analyze and study micro-markets in terms of their contributions to the Thawing Equipment market, their prospects, and individual growth trends.

To offer precise and useful details about factors affecting the growth of the Thawing Equipment

To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Thawing Equipment market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Key questions answered

How feasible is Thawing Equipment Market for long-term investment?

What are influencing factors driving the demand for Thawing Equipment near future?

What is the impact analysis of various factors in the Global Thawing Equipment market growth?

What are the recent trends in the regional market and how successful they are?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America

Browse Trending Reports:

Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[tamanna31]

Biopreservation Market by Regions, Type & Applications During 2023-2030

Biopreservation Market Size & Trends

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

PrincetonCryo.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[market-insider]

Regenerative Medicine Market Analysis: Growth, Challenges, and Key Players

The global regenerative medicine market size is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.

Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2019 according to the data published by PhRMA,. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.

Technological advancements such as stem cells, tissue engineering, and nanotechnology has made regenerative medicines a highly interdisciplinary in field. Stem cells are undifferentiated cells, which have the capability to repair and/or regenerate into other cells such as cartilage, tendons, ligaments, muscle, and bones. In July 2021, BlueRock Therapeutics received FDA approval for its pluripotent stem cell-derived dopaminergic neuron therapy, DA01, for advanced Parkinson’s disease treatment. This approval was expected to expand the company’s offerings.

Several key players are taking strategic initiatives such as new product development, strategic alliances, and others have contributed to the regenerative medicine market growth. For instance, in November 2021, Astellas Pharma, Inc. entered into an agreement with Pantherna Therapeutics GmbH to study mRNA-based regenerative medicine. Under this initiative, Astellas' high drug discovery capabilities and Pantherna's state-of-the-art mRNA platform will be used to promote research on developing a new program. In addition, in May 2021, Bayer AG entered into a collaboration with Senti Bio for gene circuit-engineered cell therapies development for regenerative medicine.

For More Details or Sample Copy please visit link @: Regenerative Medicine Market Report

Regenerative Medicine Market Report Highlights

The therapeutics segment held the largest share in the regenerative medicine market, owing to the growing aging population coupled with an increasing rate of age-related disorders.

The rise in a number of clinical trials for stem cell and tissue-based regenerative therapies along with an increase in demand for regenerative therapies is expected to positively influence the growth of the market.

Stem cell and progenitor cell-based therapies are projected to witness significant growth owing to huge investments in the R&D space and a growing number of stem cell banks

North America dominated the market in 2023 owing to the presence of a significant number of research organizations and universities which are working on R&D of stem cell-based therapies.

Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the rapid adoption of cell-based methods in the healthcare industry.

By therapeutic category, the oncology segment dominated the segment in 2023 owing to the increasing cases of cancer globally which is rising the demand for better solutions. The growing number of robust pipelines is driving the market growth.

Gain deeper insights on the market and receive your free copy with TOC now @: Regenerative Medicine Market Report We have segmented the global Regenerative Medicine market on the basis product, therapeutic category, and region

[allmarketnews]

Biobanking Market Future Aspect Analysis and Current Trends by 2024 to 2034

The Biobanking Market is crucial to the advancement of biomedical and translational research because it facilitates the collection and preservation of biological samples, including blood, tissues, and nucleic acids, which are then made available for use in studies aimed at identifying disease-relevant biomarkers. These biomarkers can then be utilized for diagnosis, prognosis, and drug response prediction. A key factor propelling the market is the increase in the quantity of research projects in this sector. These segment’s research efforts are supported by government funding available for stem cell therapies, regenerative medicine, and cell and gene therapy. Aside from this, the growing popularity of cord blood banking will support the expansion of this industry.

The Biobanking market is predicted to develop at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, when it is projected to reach USD 184.28 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 81.50 Billion in 2024.

Know More About Biobanking Market, Download Sample Report: https://wemarketresearch.com/reports/request-free-sample-pdf/biobanking-market/1124

Biobanking refers to the organized collection and maintenance of biological specimens and their associated data. These banks store a variety of samples, such as human tissues, blood, DNA, and other biological materials, along with crucial information about the donors, including their medical history, lifestyle, and genetic data. This systematic storage allows researchers to access high-quality, well-documented specimens for their studies.

Key Market Players

The Biobanking Market is dominated by a few large companies, such as

Thermo Fisher Scientific Inc.

PHC Holdings Corporation

Becton, Dickinson and Company

QIAGEN N.V.

Merck KGaA

Sampled

Avantor, Inc.

Cryoport, Inc.

Tecan Trading AG

Azenta, Inc.

Greiner Holding AG

Others

Global Biobanking Market- Segmental Analysis

By Sample Type

Human Tissues

Stem Cells

Other Biological Samples

By Application

Therapeutics

Research

Clinical Trials

By Storage Type

Manual Storage Systems

Automated Storage Systems

By End User

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Hospitals and Diagnostic Laboratories

Purchase a Copy of this Biobanking Market research report at@ https://wemarketresearch.com/purchase/biobanking-market/1124?license=single

Challenges in Biobanking

Standardization: Developing standardized procedures for sample collection, processing, and storage is essential to ensure the quality and comparability of specimens across different biobanks.

Funding and Sustainability: Maintaining biobanks requires significant financial resources. Securing long-term funding and demonstrating the value of biobanks to stakeholders are ongoing challenges.

Technological Advances: Rapid advancements in technology, such as genomics and data analytics, require biobanks to continually update their infrastructure and capabilities.

Interoperability: Facilitating data sharing and collaboration between biobanks, both nationally and internationally, is crucial for maximizing the potential of biobanked samples.

The Future of Biobanking

The future of biobanking is bright, with several promising trends and developments:

Integration with Digital Health: The integration of biobanks with digital health technologies, such as electronic health records (EHRs) and wearable devices, can provide more comprehensive data and enhance research capabilities.

Global Collaboration: Increasing international collaboration and data sharing among biobanks will help address global health challenges and accelerate medical research.

Ethical Innovations: Continued advancements in ethical frameworks and governance models will help address the complex ethical issues associated with biobanking.

Personalized Medicine: Biobanks will play a critical role in the continued development of personalized medicine, providing the samples and data needed to tailor treatments to individual patients.

Biobanking Industry: Regional Analysis

North America Market Forecast

North America dominate the Biobanking Market with the highest revenue generating market with share of more than 47%. Leading biobanking companies, robust government support, and advances in personalized medicine foster growth. Extensive R&D activities and a high prevalence of chronic diseases also contribute to the market's expansion.

Europe Market Statistics

Europe’s biobanking market thrives due to its robust regulatory frameworks, strong healthcare systems, and substantial research funding. The region's collaborative research initiatives and cross-border projects enhance biobank operations and data sharing. Supportive policies and funding for innovative research drive the growth and efficiency of biobanks across Europe.

Conclusion

Biobanking is a cornerstone of modern medical research, offering invaluable resources for understanding diseases, developing new treatments, and improving public health. By addressing ethical, legal, and operational challenges, and embracing technological advancements, biobanks can continue to drive scientific discoveries and enhance healthcare outcomes worldwide.

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Contact Us:

Mr. Robbin Joseph

Corporate Sales, USA

We Market Research

USA: +1-724-618-3925

Websites: https://wemarketresearch.com/

Email: sales@wemarketresearch.com

[wellnessweb]

Global Mesenchymal Stem Cells Market Overview

The Mesenchymal Stem Cells Market size was estimated at USD 3.11 billion in 2023 and is expected to reach USD 8.22 billion by 2031 with a growing CAGR of 12.93% during the forecast period of 2024-2031.The Mesenchymal Stem Cells (MSCs) market is poised at the intersection of groundbreaking research and therapeutic innovation, heralding a new era in regenerative medicine.

With their remarkable potential to differentiate into various cell types, MSCs have captivated the biomedical field, offering promising avenues for treating a spectrum of diseases from orthopedic injuries to autoimmune disorders. As scientific understanding deepens and clinical trials expand, the market for MSC therapies anticipates exponential growth, driven by robust investment in biotechnology and increasing healthcare demand for effective, personalized treatments. This burgeoning market not only holds the key to transformative therapies but also represents a pivotal frontier in harnessing the body's own healing mechanisms for improved patient outcomes worldwide.

Get Sample Report @ https://www.snsinsider.com/sample-request/3948

Market Scope & Overview

The most recent Mesenchymal Stem Cells Market  report offers accurate data on the market's size, share, and capacity for production, demand, and growth over the coming year. According to market research, the market is changing quickly, and both the impact on the present and the future are being examined. The market research team conducted thorough primary and secondary research to gather the relevant market data.

The market size and value for each industry, channel, and other sector are discussed in the research. It also takes into account the elements and traits that could affect the expansion of the market's sales. The market's present and future states are carefully examined in the worldwide Mesenchymal Stem Cells Market  research report.

Market Segmentation Analysis

By Products and Services

Products

Cells & Cell Lines

Kits, Media, & Reagents

Others

Services

By Workflow

Cell Sourcing & Isolation

Culture & Cryopreservation

Differentiation

Characterization

By Type

Autologous

Allogeneic

By Source of Isolation

Bone Marrow

Cord Blood

Peripheral Blood

Fallopian Tube

Fetal Liver

Lung

Adipose Tissues

By Indication

Bone And Cartilage Repair

Cardiovascular Disease

Inflammatory And Immunological Diseases

Liver Diseases

Cancer

GvHD

Others

By Application

Disease Modelling

Drug Development & Discovery

Stem Cell Banking

Tissue Engineering

Toxicology Studies

Others

COVID-19 Impact Analysis

The worldwide economy is significantly impacted by the coronavirus outbreak. The most recent COVID-19 scenario analysis is included in this Mesenchymal Stem Cells Market  research report. The top businesses, distributors, and supply chain organizations in the sector are also examined in the report.

Regional Outlook

North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are the five geographic divisions of the market. The Mesenchymal Stem Cells Market report examines each regional market in great detail and sheds light on the key factors influencing it. The research takes into account factors such as market size and share, import/export ratios, supply/demand ratios, consumer demand ratios, technological advancements, R&D, infrastructure development, and a strong market presence across the board.

Competitive Analysis

To give readers a greater understanding of the important players, the study report covers cutting-edge research approaches including SWOT and Porter's Five Forces analysis. Additionally, it includes crucial data on the economy, global positioning, product portfolios, earnings, gross profit margins, and scientific and technology advancements. The key industry partnerships, product launches, and acquisitions are the subject of the Mesenchymal Stem Cells Market  research.

Key Reasons to Purchase Mesenchymal Stem Cells Market  Research Report

Market research contains critical development status, growth rates, evaluations of the competitive environment, and data on international marketing.

The research report offers a comprehensive view of the worldwide competitive climate as well as crucial details on the leading rivals and their projected future growth.

Conclusion

For industry participants and other stakeholders looking for a thorough analysis of the current market dynamics as well as realistic estimates, the Mesenchymal Stem Cells Market  research report will be a valuable resource.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Nasal Drug Delivery Market Growth Drivers

DNA Synthesis Market Growth Drivers

Osteoporosis Treatment Market Growth Drivers

Immunomodulators Market Growth Drivers

Proteomics Market Growth Drivers

[healthcaremarketanalysis]

Biobanking Market worth $5.0 billion by 2028

Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.

Browse in-depth TOC on "Biobanking Industry"

334 - Tables

48 - Figures

398 – Pages.

Download PDF Brochure:

The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.

The blood products segment accounted for the largest share, by sample type in the biobanking market in 2022.

Based on sample type, the global biobanking market has been segmented into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. The blood products segment held the largest share of the global biobanking market in 2022. This can be attributed to the rising incidence of blood disorders and the increasing demand for various types of blood products across the globe. With the ongoing expansion of biobanks and the increasing emphasis on precision medicine, the demand for blood products in biobanking is expected to remain strong, further propelling the growth of the global biobanking market

The manual storage segment accounted for the largest share of the storage type segment in the biobanking industry in 2022.

Based on storage, the global biobanking market has been segmented into manual storage and automated storage. The manual storage segment held the larger market share in 2022. The large share of this segment can be attributed to the low cost and easy installation associated with this type of storage. Furthermore, many research centers and life science companies rely on manual processes for biological sample storage, this is further accelerating the market growth.

The North America region catered the largest share of the biobanking market in 2022.

The biobanking market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory. This can be attributed to the increasing number of biobanks and the growing investments in biobanking infrastructure. Major healthcare institutes and research organizations in North America have made substantial commitments to expanding their biobanking capabilities. Additionally, the rising prevalence of chronic diseases and the subsequent demand for personalized medicine has fueled the growth of the biobanking market in North America, with biobanks playing a pivotal role in storing and providing high-quality biological specimens for research and development purposes.

Key players in the biobanking market include Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US).

Request 10% Customization

Biobanking Market: Impact Analysis

 Drivers

Growing investments and funding for biobanks

Focus on genetic testing and precision medicine

Increasing trend in preservation of cord blood stem cells from newborns

Favorable funding scenario for research related to regenerative medicine

 Restraints

High cost of automated equipment

Issues related to biospecimen sample management

OPPORTUNITIES

Challenges

High operational cost of biobanks

Storage of samples

Recent Developments

In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.

In September 2022, Cryoport entered into a strategic partnership with BioLife Plasma Services to offer supply chain solutions and service offerings, such as bioservices and cryo-processing, for BioLife Plasma Services.

Biobanking Market Advantages:

Valuable Research Resources: Biobanks provide researchers with access to a vast collection of well-characterized biological samples and associated data. These resources serve as a valuable foundation for conducting various types of research, including genomics, proteomics, metabolomics, and epidemiological studies. Biobanks enable researchers to investigate diseases, discover new biomarkers, study genetic variations, and develop personalized therapies.

Accelerating Drug Discovery and Development: Biobanks play a crucial role in the drug discovery and development process. By providing researchers and pharmaceutical companies with access to diverse and representative samples, biobanks facilitate the identification of drug targets, testing of potential therapies, and assessment of drug efficacy and safety. This accelerates the drug development timeline, reduces costs, and enhances the success rate of clinical trials.

Facilitating Personalized Medicine: Biobanks contribute to the advancement of personalized medicine, which aims to provide tailored healthcare based on an individual's unique genetic makeup and other factors. By storing genetic information, clinical data, and biological samples, biobanks enable the identification of genetic markers associated with diseases, predicting disease risks, and guiding personalized treatment decisions. This helps healthcare providers deliver targeted therapies and improve patient outcomes.

Long-Term Sample Preservation: Biobanks employ specialized techniques and infrastructure to ensure the long-term preservation of biological samples. This enables the availability of high-quality samples over extended periods, allowing researchers to conduct longitudinal studies, analyze disease progression, and investigate long-term health outcomes. Long-term sample storage also enables retrospective studies and future research on emerging diseases or new research questions.

Collaboration and Data Sharing: Biobanks promote collaboration and data sharing among researchers, institutions, and industries. By establishing standardized protocols, ethical guidelines, and data sharing agreements, biobanks facilitate the exchange of samples, data, and knowledge. This collaboration fosters scientific discoveries, enables the replication of research findings, and maximizes the utility of stored samples.

Advancing Translational Research: Biobanks bridge the gap between basic research and clinical applications by facilitating translational research. By linking biological samples to clinical data, biobanks support the investigation of disease mechanisms, biomarker discovery, and the development of diagnostic tests. This enhances the translation of scientific knowledge into clinical practice, leading to improved disease diagnosis, prognosis, and treatment.

Overall, the biobanking market offers significant advantages by providing researchers and healthcare professionals with access to diverse, well-preserved, and well-characterized biological samples. These advantages accelerate research, drug development, and personalized medicine initiatives, ultimately contributing to advancements in healthcare and patient care.

Biobanking market - Report Highlights:

The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall biobanking industry.

The new edition includes the impact of the recession on the biobanking market (especially the region-wise impact in the geographic analysis section) in 2022. There is a variation in the growth rate of the market due to the ongoing recession.

Additional points such as ranges/scenarios, trends/disruptions impacting customers' businesses, pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, patent analysis, key conferences and events (2022-2023), list of key regulatory bodies, regulatory landscape, Porter's Five Forces analysis, key stakeholders, the influence of stakeholders on buying decisions, and buying criteria among end users have been added in the market overview chapter.

The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This will help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.

Recent developments help us to understand market trends and the growth strategies adopted by players in the market.

Tracking the portfolios of prominent market players helps analyze the major products in the biobanking market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.

Key market strategies/right to win, market share analysis for 2022, revenue share analysis of key market players from 2020 to 2022, and competitive leadership mapping have been added in the competitive landscape section of the report.

The new version of the report includes competitive leadership mapping for companies operating in the market. This new section is an output of a comprehensive study of the key vendors offering biobanking products. The top 25 vendors were shortlisted from a list of 50+ vendors, and these were evaluated based on market share/ranking and product footprint, rated and positioned on a 2x2 quadrant, referred to as Company Evaluation Quadrant, categorizing them as Stars, Emerging Leaders, Pervasive Players, and Participants.

The new version of the report includes the startup/SME evaluation quadrant for 10 companies operating in the biobanking market. This updated section is an output of a comprehensive study of the key startup vendors offering biobanking products. The top 10 vendors were shortlisted from a list of 50+ vendors, and these vendors were evaluated based on their product portfolio and business strategy, rated and positioned on a 2x2 quadrant, referred to as Competitive Leadership Quadrant, categorizing them as Progressive Companies, Starting Blocks, Responsive Companies, and Dynamic Companies.

In the new edition of the report, the Rest of the World is segmented into Latin America and the Middle East and Africa. Country-level markets for Brazil and the Rest of Latin America in the Latin American region have been added.

The new version of the report includes the ownership segment, which is further segmented into national/regional agencies, non-profit organizations, universities, and private organizations.

The new version of the report includes an end-user segment, which is further segmented into pharmaceutical & biotechnology companies and CROs, academic and research institutes, and hospitals.

Report Link: ( Biobanking Market )

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email : sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biobanking-devices-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/biobanking-devices.asp

[trendingreportz]

Tissue Banking Market - Forecast(2024 - 2030)

Tissue Banking Market Overview

The market size of Global Tissue Banking for 2019 is $42,599m and is set to grow at a CAGR of 4.0% during the forecast period 2020–2025 owing to a rise in tissue transplant cases and rising incidences of cancers, cardiovascular diseases, and diabetes. The market is witnessing several trends such as a shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, and potential cure for cancers, blood disorders, and immune and genetic diseases. With the increase in the harmonization of biobanks and research collaboration, the tissue banking market is set to grow positively during the forecast period. 

Key Takeaways

The global tissue banking market is poised to exhibit a CAGR of 4.0% percentage during the forecast period (2020–2025), attributed to rising demand for transplantation.

Major factors driving growth of the global tissue banking market is increase in the demand for regenerative medicines. 

The wide range of applications for instance storage, handling, transportation and maintenance of specimens and samples is poised to increase the market growth for the forecast period.

Request Sample

By Type - Segment Analysis

In Tissue Type segment, Blood tissue accounted for the largest share, followed by soft tissue in 2019. Blood donation has increased substantially in the past few years. In U.S., approximately 36,000 units of red blood cells are needed everyday. In Europe, approximately 1700 people opted for blood vessel tissue donation in 2013. The countries such as Spain, Italy and Sweden are the major countries with high number of donors.

By Equipment - Segment Analysis

In Equipment type, Cryopreservation Systems segment dominated the market in 2019. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities which are to be used for procedures such as organ donation, bone marrow transplant and others. 

Inquiry Before Buying

By Application - Segment Analysis 

In 2019, Clinical/ Therapeutic dominated the Application segment of Tissue banking market and is set to grow at a CAGR of 4.3%. Tissues preserved in tissue banks can be used for fulfilling variety of medical needs of people for example heart valves can be used in patients with heart disorders, corneal transplantation used to give visibility to blind people, tendons and ligaments used in  orthopedic surgery and blood to treat blood disorders. Clinical/therapeutic applications majorly use tissue banking for it involves different types of grafting such as cord blood, stem cell and others. 

By Geography - Segment Analysis

North America region held 35% of the global tissue banking market in 2019. This is owing to advanced technology and high awareness regarding tissue donation among the medical personnel and healthcare professionals. Europe is set to attain a significant growth owing to the increasing geriatric population and unhealthy lifestyle prevailing in the region. Asia-Pacific is poised to record rapid growth rates on the account of government initiatives for expanding medical facilities coupled with the presence of key market players in the region.

Schedule a Call

Drivers – Tissue Banking Market

Increasing Technological Advancement

Technological advancement in the healthcare sector such as development in biobanking technology coupled with a rise in regenerative tissue demand drives the market growth. The regenerative medicines cure different kinds of damaged tissues covering aging issues to injuries, which is poised to drive the demand for the Tissue Banking Market.

Challenges – Tissue Banking Market

High Cost Associated With Transplantation Procedures

The high transplant cost, bioethical issues and unavailability of tissue banks in many remote countries coupled with stringent government rules and regulations regarding testing and clearance documents negatively impact the growth of the global tissue banking market over the forecast period. 

Buy Now

The Major Players in this Market Include

The leading players in the tissue banking market are AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA and Thermo Fisher Scientific, Inc.

Acquisitions/Product Launches:

In 2017, Natera, a leader in genetic testing, launched Evercord, a new offering that enables expectant parents to collect, store, and potentially retrieve their newborn’s cord, blood, and tissue for therapeutic use in transplantation and regenerative medicine applications.

In 2013, three institutes at the National Institute of Health, including the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Child Health and Human Development (NICHD) launched a joint initiative called as ‘NeuroBioBank’ in the U.S. It links together six large organ and tissue repositories through a common web portal.

In October 2018, MTF Biologics announced the formation of a new tissue recovery relationship with Regenerative Biologics, Inc. The organizations seek to provide expanded birth-tissue donation opportunities for expectant mothers and their families and enhance patients’ access to high-quality placental tissues for wound care applications.

[lalsingh228-blog]

Stem Cells Market to enjoy 'explosive growth' to 2030

The Latest research coverage on Stem Cells Market provides a detailed overview and accurate market size. The study is designed considering current and historical trends, market development and business strategies taken up by leaders and new industry players entering the market. Furthermore, study includes an in-depth analysis of global and regional markets along with country level market size breakdown to identify potential gaps and opportunities to better investigate market status, development activity, value and growth patterns. Access Sample Report + All Related Graphs & Charts @: https://marketresearchforecast.com/report/stem-cells-market-528/sample-report

Major & Emerging Players in Stem Cells Market:- PromoCell GmbH (Germany), AcceGen (U.S.), Bio-Techne (U.S.), Cellular Engineering Technologies (U.S.), Merck KgaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Lonza (Switzerland), Miltenyi Biotec B.V. & Co. KG (Germany), STEMCELL Technologies (Canada) The Stem Cells Market Study by Market Research Forecast gives an essential tool and source to Industry stakeholders to figure out the market and other fundamental technicalities, covering growth, opportunities, competitive scenarios, and key trends in the Stem Cells market. The application of stem cells to the management of many physiological ailments is becoming more and more common. Technology developments in the pharmaceutical and healthcare industries provide investors in the stem cells industry significant income opportunities. The global market is expanding due to increased spending in research and development initiatives that seek to identify new uses for stem cells in various healthcare areas. In addition, there is an increased need for stem cells due to the growing prevalence of illnesses such as diabetes, cancer, and heart disease. Industry players are presently investigating novel approaches to cultivate and utilise stem cells for various applications. The market is growing even more as a result of the pharmaceutical industry's and clinical research institutions' rapid expansion in developed regions.However, a significant obstacle to commercial expansion is the high prices connected with stem cell operations. As a result, businesses in the stem cell sector are encouraged to try out new methods in order to improve testing procedures and advance the field. The titled segments and sub-section of the market are illuminated below: by Cell Type ( Embryonic Stem Cells (ESCs), by Application ( Research and Clinical), by End-user ( Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others)by North America ( U.S. ,Canada ), by Europe ( U.K. ,Germany ,France ,Italy ,Spain ,Scandinavia ,Rest of Europe ), by Asia Pacific ( Japan ,China ,India ,Australia ,South Korea ,Southeast Asia ,Rest of Asia Pacific ), by Latin America ( Brazil ,Mexico ,Rest of Latin America ), by The Middle East & Africa ( South Africa ,GCC ,Rest of the Middle East & Africa ) Forecast 2024-2031 Stem Cells Trends:

Personalized medicine: Stem cells offer personalized therapies tailored to individual patients.

Stem cell banking: The storage of stem cells for future therapeutic use is becoming increasingly popular.

Tissue engineering: Stem cells are used to create functional tissues for transplantation and regenerative medicine.

Emerging Trends in Stem Cells:

Induced pluripotent stem cells (iPSCs): These cells are reprogrammed from adult somatic cells, reducing the ethical concerns associated with embryonic stem cells.

Gene editing technologies: CRISPR-Cas9 and other gene editing tools enable precise modifications to stem cells, improving their therapeutic potential.

Bioprinting of stem cells: 3D printing techniques are being used to create complex tissue structures from stem cell populations. Enquire for customization in Report @: https://marketresearchforecast.com/report/stem-cells-market-528/enquiry-before-buy

Significant developments in Stem Cells Sector:

December 2023: GenCure and the University of Texas at San Antonio (UTSA) collaborated to develop cellular therapy products, services, and testing.

August 2023: BlueRock Therapeutics LP and bit.bio signed an agreement for the discovery, development, and manufacturing of iPSC-derived regulatory T cells (Tregs).

July 2023: PromoCell GmbH launched the PromoExQ MSC Growth Medium XF for in-vitro expansion of human Mesenchymal Stem Cells (hMSCs).

July 2023: Pluristyx, Inc. partnered with Stem Genomics to evaluate the genomic stability of Pluristyx's Pluripotent Stem Cell (PSC) lines.

June 2023: FUJIFILM Cellular Dynamics launched its human iPSC-derived iCell Blood-Brain Barrier Isogenic Kit for drug discovery in neuroactive medicines. Some Point of Table of Content: Chapter One: Report Overview Chapter Two: Global Market Growth Trends Chapter Three: Value Chain of Stem Cells Market Chapter Four: Players Profiles Chapter Five: Global Stem Cells Market Analysis by Regions Chapter Six: North America Stem Cells Market Analysis by Countries Chapter Seven: Europe Stem Cells Market Analysis by Countries Chapter Eight: Asia-Pacific Stem Cells Market Analysis by Countries Chapter Nine: Middle East and Africa Stem Cells Market Analysis by Countries Chapter Ten: South America Stem Cells Market Analysis by Countries Chapter Eleven: Global Stem Cells Market Segment by Types Chapter Twelve: Global Stem Cells Market Segment by Applications What are the market factors that are explained in the Stem Cells Market report?

– Key Strategic Developments: Strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors.

– Key Market Features: Including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin.– Analytical Tools: The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market. Buy This Exclusive Research Here: https://marketresearchforecast.com/report/stem-cells-market-528/checkout?type=corporate Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. Contact US : Craig Francis (PR & Marketing Manager) Market Research Forecast Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[themarketinsights]

Stem Cell Banking Market to See Major Growth by 2028

Latest released the research study on Global Stem Cell Banking Market, offers a detailed overview of the factors influencing the global business scope. Stem Cell Banking Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Stem Cell Banking The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Cord Blood Registry Systems (United States), Cordlife (Singapore), Cryo-Cell International (United States), Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands), LifeCell International (India), StemCyte (United States), ViaCord (A Subsidiary of Perkinelmer) (United States), Global Cord Blood (China) , Smart Cells International Ltd. (United Kingdom), Vita 34 International (Germany),

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/20849-global-stem-cell-banking-market

Stem Cell Banking Market Definition:

Stem cell banking is the extraction, processing, and storage of stem cells, so that they may be used for treatment in the future when required. Stem Cells have the amazing power to transform into any tissue or organ in the human body. Stem cells have a unique characteristic & the potential to treat over 80 life-threatening diseases and offers numerous benefits to the baby, its siblings and the family. Furthermore, it is being extensively used in personalized banking, research, and clinical applications.

Market Trend:

Rapid Advancements in Biotechnology Field

Market Drivers:

Growing Awareness of the Therapeutic Potential of Stem Cells

Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage

Increase in HematopOIEtic Stem Cell Transplantation Procedures

Increasing Investments in Stem Cell-Based

Market Opportunities:

Emerging Countries

Rising Global Burden of Major Diseases

 

The Global Stem Cell Banking Market segments and Market Data Break Down are illuminated below:

by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others), Application (Personalized Banking Applications, Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}, Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}), Service (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Source (Placental Stem Cells (PSCs), Human Embryo-derived Stem Cells (hESCs), Bone Marrow-derived Stem Cells (BMSCs), Adipose Tissue-derived Stem Cells (ADSCs), Dental Pulp-derived Stem Cells (DPSCs), Other Stem Cell Sources)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/20849-global-stem-cell-banking-market

Strategic Points Covered in Table of Content of Global Stem Cell Banking Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Stem Cell Banking market

Chapter 2: Exclusive Summary – the basic information of the Stem Cell Banking Market.

Chapter 3: Displayingthe Market Dynamics- Drivers, Trends and Challenges of the Stem Cell Banking

Chapter 4: Presenting the Stem Cell Banking Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Stem Cell Banking market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2026).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Stem Cell Banking Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology The primary sources involves the industry experts from the Global Stem Cell Banking Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/20849-global-stem-cell-banking-market

What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837

[industrynewsupdates]

Biopreservation Market Key Companies, Growth and Forecast Report, 2030

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Marke

Biopreservation Market Report Highlights

• By product, the equipment segment held the largest revenue share of over 78.75% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Increasing demand for modified genetic material in the global market is also fueling the growth

• The bio-banking application segment held the largest revenue share in 2022. This can be attributed to rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals

• North America dominated the global market in 2022 due to the advancement in biomedical research, the development of advanced therapies, and the upsurge in research activities related to DNA sequencing and bioinformatics

• Asia Pacific is expected to grow considerably in the future owing to rising investments in Asian countries and increasing partnerships and collaborations with key players

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

• The global DNA methylation market size was valued at USD 1.47 billion in 2023. It is expected to expand at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2030.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market on the basis of product, application, and region:

Biopreservation Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment

o Freezers

o Refrigerators

o Consumables

o Vials

o Straws

o Microtiter Plates

o Bags

o Liquid Nitrogen

• Media

o Pre-formulated

o Home-brew

• Laboratory Information Management System (LIMS)

Biopreservation Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Regenerative Medicine

o Cell Therapy

o Gene Therapy

o Others

• Bio-banking

o Human Eggs

o Human Sperms

o Veterinary IVF

• Drug Discovery

Biopreservation Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[businesspointnews]

Stem Cell Banking Market Size, Demand, Share and Forecast 2023-2028

IMARC Group has recently released a new research study titled “Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Stem Cell Banking Market Size, CAGR and Forecast…

[rohans18]

Thawing Equipment Market Applications and Current Status

Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.

In the consistent Thawing Equipment market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Thawing Equipment industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Thawing Equipment market report brings precise and exact market research information that drives business into the right direction.

Key Players

Cyanotech Corporation (U.S.)

I.D. - Parry (India) Limited (India)

BlueBioTech International GmbH (Germany)

Algatech Ltd. (Israel)

Tianjin Norland Biotech Co., Ltd. (China)

AlgaeCan Biotech Ltd. (Canada)

AstaReal AB (Sweden)

Yunnan Alphy Biotech Co., Ltd. (China)

Fenchem (China)

Piveg, Inc. (U.S.)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-thawing-equipment-market

The research studies entailed in the winning Thawing Equipment market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Thawing Equipment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market